To Screen or Not to Screen (for Skin Cancer) – Reframing the Question
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 29 July 2016
To screen or not to screen actually isn’t the question While an adaptation of Hamlet’s famous phrase may capture the headlines on whole-body skin checks, a deeper dive gets us closer to questions of life and death.
Highlights from the National Cancer Moonshot Summit
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 7 July 2016 In Events, News
The National Cancer Moonshot was announced by President Obama in his State of the Union Address in January 2016 and VP Biden was charged with spearheading the effort. Few would disagree with Mr. Biden’s selection as leader given the personal experience he and his family endured with the loss of...
Understanding Immunotherapy Part 3: CTLA-4
Now that you’ve read our background on immunotherapy and learned about PD-1, it’s time to focus on another protein that plays a key role in cancer development, CTLA-4. What is CTLA-4? In addition to displaying PD-1 on the cell surface, T cells also display CTLA-4.
Trena's Story: An African-American Retiree's Journey with Melanoma
8 June 2016 In Melanoma Stories
“Trena, you have melanoma and you are going to lose your toe. “ WHAT?!?! I am a Black woman in her sixties—that is crazy!! [caption id="attachment_1733" align="alignleft" width="255"] Trena with her boyfriend, Maceo.[/caption] My name is Trena Brown.
Insider’s Tips for Melanoma Prevention: Make Every Day Don’t Fry Day
27 May 2016 In Prevention
The Friday before Memorial Day weekend in the U.S. is Don’t Fry Day – a day to remember to keep your skin safe as we launch into the summer season here in the northern hemisphere. Why you should care – the case for every day as Don’t Fry DayMost people...
Whither melanoma and whither cancer research?
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 May 2016 In Events, Prevention, Science, Treatment
There is no doubt that the last few years have seen incredible progress for melanoma patients with 11 treatments approved since MRA’s founding in 2007: personalized medicine, targeted therapy, immunotherapy. What remains to be done for melanoma and other cancers? How are the successes in melanoma and other research areas...
Guest Post from the Polka Dot Mama
This week, we’re featuring a guest post from Tracy Callahan, who founded and leads the Polka Dot Mama Melanoma Foundation. My name is Tracy Callahan and I am the Founder and CEO of the Polka Dot Mama Melanoma Foundation established in 2015.
A Daughter Reflects on Her Father’s Battle with Melanoma
This week, we feature a guest post by Samantha Stinchcomb, a student at the University of Delaware. When her father succumbed to melanoma, Samantha and her family and friends founded the Wayne Stinchcomb Big Orange Foundation to raise money for melanoma research and to educate her local community about the disease...
Research Q&A: Dr. Tim Bullock
21 March 2016 In Science
In the latest blog post, we chatted with the University of Virginia’s Tim Bullock, Ph.D., a tumor immunologist in the Pathology Department and MRA-funded investigator. Read on to learn what he has to say about melanoma research and prevention efforts.
A Daughter's Take: My Mother’s Journey
This week, we're pleased to welcome our youngest guest blogger, Sadie Kargman. Sadie's sharing her family's personal experience with melanoma and has committed to helping support MRA through fundraising. Read more. Hi, my name is Sadie and when I was only in second grade my mom was diagnosed with melanoma.
Adjuvant Therapy Advocacy ASCO Awareness Board Members BRAF Cancer Combination Therapy Detection FDA Grants Immunotherapy Melanoma microbiome MRA Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Research Science Social Media Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People